Neoadjuvant letrozole and palbociclib in patients with HR-positive/HER2-negative early breast cancer and Oncotype DX Recurrence Score ≥18: DxCARTES study – ESMO OPEN

Guerrero-Zotano, A; Pérez-García, JM; Ruiz-Borrego, M; Bermejo, B; Gil-Gil, M; de la Haba, J; Conejo, EA; Quiroga, ; Carañana, ; Urruticoechea, A; Morales, S; Bellet, M; Antón, A; Fernández-Abad, M; Sánchez-Rovira, P; Calabuig, L; Pérez-Escuredo, J; Sampayo-Cordero, M; Cortés, J; Llombart-Cussac, A – 2024 – 10.1016/j.esmoop.2024.103733